Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
See Latest ArticlesEconomic evaluation of nonsteroidal anti-inflammatory drug strategies in rheumatoid arthritis
International Journal of Technology Assessment in Health Care, 04/17/09
Inotai A et al. - The authors model indicates that NSAID + PPI offers extra health gain for extra costs compared with conventional NSAIDs, while it dominates celecoxib because of celecoxib's higher costs and lower effectiveness. According to the sensitivity analyses, QALYs had the highest influence on ICER.
Related Articles
Can economic evaluation of telemedicine be trusted
Cost Effectiveness and Resource Allocation, 10/26/09
Relevance Score: 69%
Computer-aided system for health economic evaluation
Journal of Evaluation in Clinical Practice, 10/02/09
Relevance Score: 69%
Methodological Assessment of Economic Evaluations of Alcohol Treatment: What Is Missing
Alcohol and Alcoholism, 10/12/09
Relevance Score: 67%
Economic Evaluation of Sinfrontal in the Treatment of Acute Maxillary Sinusitis in Adults
Applied Health Economics and Health Policy, 10/20/09
Relevance Score: 66%
Impact of the 1997 Canadian Guidelines on the Conduct of Canadian-Based Economic Evaluations in the Published Literature
Value in Health, 10/13/09
Relevance Score: 66%
Today in Economics of Medicine...keeping you current
Receive free subspecialty "5-minute updates" via email
HHS Gets Advice on Incentive Definitions
HealthDataManagement, 12/16/09
Presidential order targets improper federal payments
American Hospital Association News, 12/15/09
Community safety net
American Hospital Association News, 12/14/09
Sponsor
Article Search
Sponsor
Sponsor